PJ, March 2023, Vol 310, No 7971

High drug prices not justified by research and development spending, US analysis claims

Analysis by health economists show that the median price of newly launched prescription drugs in the United States rose from US$1,400 per year in 2008 to more than US$150,000 per year in 2021.…

Drug manufacturers propose 7% levy on company profits to replace existing voluntary scheme

The Department of Health and Social Care says the proposed new 'Voluntary scheme for pricing, access and growth' — through which manufacturers would pay a fixed levy of 6.9% on profits made from selling medicines to the NHS — would be "completely unaffordable".…

Apps for treatment of anxiety and depression in adults provisionally approved by NICE

The eight digital therapies include treatments for body dysmorphic disorder and post-traumatic stress disorder.…

Nitrous oxide could be harming people as much as the planet

Why healthcare workers have a duty to act now to prevent nitrous oxide waste.…